AIGH Capital Management’s Biodesix BDSX Stock Holding History

AIGH Capital Management’s Portfolio BDSX Stock Details BDSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.3M	Sell	678,328 -80,000	-11%	-$1.19M	0.96%	20
2026 Q1	$11M	Buy	+758,328	New	+$9.4M	1.5%	21
2025 Q2	–	Sell	-213,630	Closed	-$2.67M	–	38
2025 Q1	$2.67M	Sell	213,630 -95,361	-31%	-$1.83M	1.11%	27
2024 Q4	$9.46M	Buy	308,991 +25,000	+9%	+$736K	2.96%	14
2024 Q3	$10.1M	Sell	283,991 -5,000	-2%	-$172K	2.85%	10
2024 Q2	$8.84M	Buy	288,991 +122,937	+74%	+$3.51M	2.75%	9
2024 Q1	$4.75M	Sell	166,054 -66,893	-29%	-$2.29M	1.43%	25
2023 Q4	$8.57M	Sell	232,947 -12,388	-5%	-$389K	3.39%	10
2023 Q3	$8.1M	Sell	245,335 -7,736	-3%	-$215K	3.83%	10
2023 Q2	$6.23M	Sell	253,071 -24,156	-9%	-$724K	2.54%	11
2023 Q1	$10.3M	Sell	277,227 -27,447	-9%	-$1.13M	3.8%	8
2022 Q4	$14M	Buy	+304,674	New	+$8.28M	4.62%	9

Other funds holding BDSX

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

TAM

Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIM

Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

AIGH Capital Management's BDSX Position: Q2 2026 in Review

AIGH Capital Management reduced its Biodesix (BDSX) stake by 11% in Q2 2026, selling an estimated $1.19M and leaving 678,328 shares worth $15.3M. The position accounts for 0.96% of the portfolio, ranked #20.

AIGH Capital Management first reported a position in BDSX in Q4 2022 and has held it in 12 quarters since. 45 funds tracked by Wall St. Rank hold BDSX as of Q2 2026.

AIGH Capital Management held 678,328 shares of Biodesix worth $15.3M as of Q2 2026.
AIGH Capital Management sold 80,000 Biodesix shares in Q2 2026, an estimated $1.19M.
Biodesix made up 0.96% of AIGH Capital Management's portfolio in Q2 2026, its #20 holding.
AIGH Capital Management first reported a position in Biodesix in Q4 2022 and has held it in 12 quarters since.
45 funds tracked by Wall St. Rank held Biodesix as of Q2 2026.

Based on AIGH Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.